Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography
- 7 July 2000
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 744 (1) , 65-71
- https://doi.org/10.1016/s0378-4347(00)00231-0
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- HPLC-UV method for the quantitation of nevirapine in biological matrices following solid phase extraction.Journal of Pharmaceutical and Biomedical Analysis, 1999
- Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected PatientsJAMA, 1998
- Pharmacokinetics, Safety, and Activity of Nevirapine in Human Immunodeficiency Virus Type 1-Infected ChildrenThe Journal of Infectious Diseases, 1996
- Drug Evaluations Anti-infectives: Nevirapine: A review of its development, pharmacological profile and potential for clinical useExpert Opinion on Investigational Drugs, 1996